TFXNYSESEC EDGAREDGAR

TELEFLEX INC

Surgical & Medical Instruments & Apparatus·WAYNE, PA·FY end 12/31·CIK 96943

Board of Directors

3 members · 2 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Stephen K. Klasko, M.D.Chair
Stuart A. RandleCEO and Director
KrakauerDirector

Risk-factor diff

FY 2025 10-K vs. FY 2024
+20 new21 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

could harm our business by discouraging customers’ selection of, and reducing the prices they are willing to pay for, our products.

NEW · FY 2025

$150,000 per year (and up to an aggregate of $1 million per year for “knowing failures”), as adjusted annually for inflation.

NEW · FY 2025

The strategic transformation that we are currently implementing may not have the intended results and may be harmful to our business.

NEW · FY 2025

In February 2025, we announced our intention to undertake a strategic transformation of the organization. In accordance with this strategy, on December 9, 2025, with the simultaneous execution of definitive agreements to sell our Acute Care and Interventional Urology businesses to Intersurgical® Ltd and the OEM business to Montagu and Kohlberg (collectively referred to as the "Strategic Divestitures"). The combined transaction total of Strategic Divestitures is $2.0 billion in cash, consisting of expected proceeds of approximately $1.5 billion for our OEM business and $530 million for our Acut…

NEW · FY 2025

However, we can make no assurance that the announced transactions will be consummated on the timeframe contemplated or at all. We will face significant challenges in connection with first consummating, and then managing our business following the Strategic Divestitures. These challenges include, without limitation, obtaining the regulatory approvals necessary for, and satisfying the closing conditions to, the transactions, and the diversion of management’s attention from ongoing business concerns to completing the transactions. Then, both in the period before the transactions are consummated a…

+ 15 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.